Navigation Links
Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
Date:2/25/2008

Harris Expands Enterprise Intelligence Systems to Healthcare Market

ORLANDO, Fla., Feb. 25 /PRNewswire-FirstCall/ -- HIMSS, Booth #1841 -- Harris Corporation (NYSE: HRS), an international communications and information technology company, has joined forces with Cancer Treatment Services International (CTSI) to advance the quality and delivery of radiation oncology. Harris will provide advanced imaging and information systems that assure critical medical information is delivered with accuracy, speed, security and privacy.

"We believe Harris' expertise in image processing and enterprise intelligence will significantly advance radiation oncology," said Dr. Jeff Shogan, MD and chairman of CTSI. "Our collaboration with Harris will enhance our ability to deliver the highest quality cancer treatment services to more people, more effectively."

"We are very pleased to be working with CTSI and Dr. Shogan, who is a leading practitioner and innovator in cancer treatment services on an international scale," said Jim Traficant, vice president of Harris Healthcare Solutions. "We have been working closely with Dr. Shogan to leverage our imaging and informatics expertise to deliver enterprise intelligence to radiation oncology."

CTSI L.P. is a provider of comprehensive treatment for cancer patients with a main focus on medical oncology and radiation oncology. The company was founded by a core group of physicians and businessmen with substantial experience in the development, operation and networking of cancer services on a national and international level. CTSI is able to provide innovative and technologically-advanced treatment solutions to areas of the world where therapy is currently inadequate in either quality or capacity.
'/>"/>

SOURCE Harris Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. CEL-SCI Corporation Releases Letter to Shareholders
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
7. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
8. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
9. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
11. Immunosyn Corporation Releases SF-1019 Study Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...E, N.J., Nov. 25 Regado Bioscience...t of antithrombotic aptamers with active control a...esident, will be presenting at the Piper Jaffray 2...Palace Hotel in New York City. Dr. Mazzo,s presen...ecember 1 and will include an overview of the Comp...
(Date:11/25/2009)...lif., Nov. 25 Abaxis, In...nufacturing point-of-care blood analysis systems, ...chief executive officer, will present at the 21st ...nesday, December 2, 2009 at 2:00 p.m. ET. The conf...n New York City. ,, About Abaxis ,, Abaxi...
(Date:11/25/2009)...LL, N.C., Nov. 25 Cempra Pharmaceu...ndes, president and chief executive officer, will ...re Conference at 8:50 a.m. EST, December 1, 2009, .... Fernandes will provide an overview of the compan...he treatment of drug-resistant pathogens including...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 1The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 55198 2Chronic Media Multi Tasking Makes It Harder to Focus 55193 1Chronic Media Multi Tasking Makes It Harder to Focus 55193 2Chronic Media Multi Tasking Makes It Harder to Focus 55193 3Encorium Reports Second Quarter 2009 Financial Results 13673 1Encorium Reports Second Quarter 2009 Financial Results 13673 2Encorium Reports Second Quarter 2009 Financial Results 13673 3Encorium Reports Second Quarter 2009 Financial Results 13673 4Encorium Reports Second Quarter 2009 Financial Results 13673 5Encorium Reports Second Quarter 2009 Financial Results 13673 6Encorium Reports Second Quarter 2009 Financial Results 13673 7Encorium Reports Second Quarter 2009 Financial Results 13673 8Encorium Reports Second Quarter 2009 Financial Results 13673 9
...niversity Medical Center Only Illinois Site in Tri...s who received an,new intravenous adult stem cell ...er of adverse events, such as cardiac,arrhythmias,...nd,global function compared to those who received ...ta presented at the American College,of Cardiology...
...resentation of Comparative Data from ECLIPSE, Larg... Agents, NEW ORLEANS, March 27, 2007 /PRNewswire-F...onal drug Cleviprex(TM) (clevidipine),compared to ...trolling perioperative hypertension -- a potential..., during and/or after,surgery -- were presented fo...
Other Medicine Technology:Heart Attack Patients Treated With Novel Stem Cell Therapy,Experience Significant Improvement in Heart and Lung Function 2Heart Attack Patients Treated With Novel Stem Cell Therapy,Experience Significant Improvement in Heart and Lung Function 3Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 2Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 3Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 4Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 5
(Date:11/27/2009)..., DALLAS, Nov. 27 Co...procedure only 25 years ago, solid organ transplan...hanks to the extraordinary men and women who gathe...11. Leaders came together from medical centers aro... Baylor Regional Transplant Institute (BRTI), one ...
(Date:11/27/2009)..., ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNewswi...lth care provider and fortunately every year, new ...ention. But do all vaccines boost immunity for the...onal ,booster shots, needed to keep immunity stron...e Journal of the American Academy of Pediatrics, M...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-Fi... SHMR ) ( "Shamir" ), a leading provider of innova...s market, announced today that its board of direct...regate amount of US$ 10 million (approximately NIS...esentative rate of exchange), or approximately US$...
(Date:11/27/2009)... and cycling plus low-emission vehicles may reduce... , FRIDAY, Nov. 27 (HealthDay News) -- Encouragin...ng cars would offer much greater public health ben..., U.K. researchers have found. , The study comp...native urban land transport scenarios for London, ...
(Date:11/27/2009)... , SEATTLE, Nov. 27 /PRNewswire/...received record-high Thanksgiving traffic numbers,...e Thanksgiving, providing a clear picture of what .... The average Thanksgiving meal in 2009 weighed in...se from last year,s feast. According to the Allrec...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4
...manian government officials traveled halfway aroun... (CSHL), to lend their support and extend their gr...ue transmissible and rapidly spreading cancer that...sciences is committing resources to sequence parts...
...Most Complete Submission Linking Capabilities, PH...,part of The Thomson Corporation (NYSE: TOC ; TSX...ns to the worldwide research and business,communit...ence management to its enhanced functionality set....
...ise for human protection in future , , MON... placed under the tongue might one day ward off th...ted only in mice, be more convenient, it also appe...le who are afraid of needles, but it,s clearly an ...
...e University researchers is the first to conduct a...nce of factors that contribute to DNA mutations, w...ical disorders. Led by assistant professor of bio... of microsatellites -- variable-length sequences o...
.... 28 Noting recent crises,involving the safety of...ngs of a governmental blue ribbon panel, Jim Marti...e U.S. Food & Drug Administration "itself a,threat...organize and renew the agency as the,safeguard of ...
...American Academy of,Pediatrics (AAP) is demanding ...duled for Thursday, January 31. As reported in The... argues in court that a vaccine caused a,child,s a...impression; the jury awards the mother $5.2 millio...
Other Medicine News:Health News:Cold Spring Harbor Laboratory researchers race against time to save Tasmanian devils 2Health News:Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities 2Health News:Drop of Flu Vaccine Under Tongue Bars Infection 2Health News:Scientists explore factors contributing to DNA mutations 2Health News:Scientists explore factors contributing to DNA mutations 3Health News:Scientists explore factors contributing to DNA mutations 4Health News:Don't Overburden FDA 2Health News:American Academy of Pediatrics Calls for Cancellation of ABC's 'Eli Stone' Premiere 2
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: